Upcoming Dividend • Jul 30
Upcoming dividend of ₩80.00 per share Eligible shareholders must have bought the stock before 06 August 2026. Payment date: 21 August 2026. Trailing yield: 3.7%. Lower than top quartile of South Korean dividend payers (4.7%). Higher than average of industry peers (1.9%). New Risk • Mar 21
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 18% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩132.5b market cap, or US$88.1m). Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩5,100, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 47% over the past three years. Ankündigung • Feb 26
Green Chemical Co., Ltd., Annual General Meeting, Mar 25, 2026 Green Chemical Co., Ltd., Annual General Meeting, Mar 25, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 103, dokgot 2-ro, daesan-eup, chungcheongnam-do, seosan South Korea Upcoming Dividend • Feb 25
Upcoming dividend of ₩160 per share Eligible shareholders must have bought the stock before 04 March 2026. Payment date: 10 April 2026. Trailing yield: 2.6%. Lower than top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (1.1%). New Risk • Jan 07
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩142.3b (US$98.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩142.3b market cap, or US$98.3m). Reported Earnings • Nov 20
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: ₩77.3b (down 6.3% from 3Q 2024). Net income: ₩4.52b (up ₩4.20b from 3Q 2024). Profit margin: 5.9% (up from 0.4% in 3Q 2024). The increase in margin was driven by lower expenses. Upcoming Dividend • Jul 22
Upcoming dividend of ₩80.00 per share Eligible shareholders must have bought the stock before 29 July 2025. Payment date: 13 August 2025. Trailing yield: 2.0%. Lower than top quartile of South Korean dividend payers (3.4%). Higher than average of industry peers (1.4%). Valuation Update With 7 Day Price Move • Apr 29
Investor sentiment deteriorates as stock falls 23% After last week's 23% share price decline to ₩7,840, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 12% over the past three years. Valuation Update With 7 Day Price Move • Apr 10
Investor sentiment improves as stock rises 34% After last week's 34% share price gain to ₩7,470, the stock trades at a trailing P/E ratio of 21.3x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 17% over the past three years. New Risk • Mar 20
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩145.3b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩145.3b market cap, or US$99.1m). Upcoming Dividend • Feb 25
Upcoming dividend of ₩160 per share Eligible shareholders must have bought the stock before 04 March 2025. Payment date: 10 April 2025. Trailing yield: 2.3%. Lower than top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.0%). Ankündigung • Feb 25
Green Chemical Co., Ltd., Annual General Meeting, Mar 26, 2025 Green Chemical Co., Ltd., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 103, dokgot 2-ro, daesan-eup, chungcheongnam-do, seosan South Korea New Risk • Jan 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change). Upcoming Dividend • Dec 20
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 09 April 2025. Trailing yield: 2.4%. Lower than top quartile of South Korean dividend payers (3.9%). In line with average of industry peers (2.2%). Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩4,995, the stock trades at a trailing P/E ratio of 22.9x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 41% over the past three years. Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩5,010, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Total loss to shareholders of 45% over the past three years. New Risk • Oct 23
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩137.9b (US$99.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 12% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩137.9b market cap, or US$99.8m). New Risk • Aug 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.1% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.5% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩130.6b market cap, or US$95.7m). Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to ₩5,560, the stock trades at a trailing P/E ratio of 33.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 51% over the past three years. Upcoming Dividend • Jul 22
Upcoming dividend of ₩80.00 per share Eligible shareholders must have bought the stock before 29 July 2024. Payment date: 14 August 2024. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (3.6%). Higher than average of industry peers (1.7%). Valuation Update With 7 Day Price Move • May 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩8,820, the stock trades at a trailing P/E ratio of 61.4x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 18% over the past three years. New Risk • Mar 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.8% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to ₩9,310, the stock trades at a trailing P/E ratio of 64.8x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 23% over the past three years. New Risk • Mar 15
New major risk - Revenue and earnings growth Earnings have declined by 1.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Upcoming Dividend • Dec 20
Upcoming dividend of ₩150 per share at 2.3% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 11 April 2024. Trailing yield: 2.3%. Lower than top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%). New Risk • Oct 26
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩133.7b (US$98.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩133.7b market cap, or US$98.4m). Buying Opportunity • Oct 26
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 30%. The fair value is estimated to be ₩7,343, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Meanwhile, the company became loss making. Upcoming Dividend • Jun 22
Upcoming dividend of ₩80.00 per share at 1.6% yield Eligible shareholders must have bought the stock before 29 June 2023. Payment date: 10 August 2023. Trailing yield: 1.6%. Lower than top quartile of South Korean dividend payers (3.2%). In line with average of industry peers (1.5%). Upcoming Dividend • Dec 21
Upcoming dividend of ₩150 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 10 April 2023. Trailing yield: 1.5%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%). Valuation Update With 7 Day Price Move • Nov 29
Investor sentiment improved over the past week After last week's 15% share price gain to ₩13,450, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 353% over the past three years. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Nov 08
Investor sentiment improved over the past week After last week's 15% share price gain to ₩11,750, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 301% over the past three years. Valuation Update With 7 Day Price Move • Oct 25
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₩10,150, the stock trades at a trailing P/E ratio of 12.1x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 253% over the past three years. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment improved over the past week After last week's 16% share price gain to ₩9,280, the stock trades at a trailing P/E ratio of 11.1x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 261% over the past three years. Valuation Update With 7 Day Price Move • Jul 27
Investor sentiment improved over the past week After last week's 18% share price gain to ₩8,670, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 234% over the past three years. Upcoming Dividend • Jun 22
Upcoming dividend of ₩70.00 per share Eligible shareholders must have bought the stock before 29 June 2022. Payment date: 10 August 2022. Trailing yield: 2.0%. Lower than top quartile of South Korean dividend payers (3.2%). Lower than average of industry peers (2.4%). Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩7,970, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 174% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improved over the past week After last week's 15% share price gain to ₩10,500, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 299% over the past three years. Valuation Update With 7 Day Price Move • Jan 25
Investor sentiment improved over the past week After last week's 22% share price gain to ₩10,750, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 301% over the past three years. Upcoming Dividend • Dec 22
Inaugural dividend of ₩140 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. The company is not currently making a profit but it is cash flow positive. The company last paid an ordinary dividend in March 2011. The average dividend yield among industry peers is 1.5%. Valuation Update With 7 Day Price Move • Oct 19
Investor sentiment improved over the past week After last week's 17% share price gain to ₩11,100, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 278% over the past three years. Upcoming Dividend • Jun 23
Inaugural dividend of ₩70.00 per share Eligible shareholders must have bought the stock before 29 June 2021. Payment date: 25 August 2021. The company last paid an ordinary dividend in March 2011. The average dividend yield among industry peers is 1.4%. Ankündigung • May 26
Green Chemical Co., Ltd. (KOSE:A083420) agree to acquire 8% stake in KPX Lifescience.Co.,Ltd. (KOSDAQ:A114450) for KRW 15.3 billion Green Chemical Co., Ltd. (KOSE:A083420) agree to acquire 8% stake in KPX Lifescience.Co.,Ltd. (KOSDAQ:A114450) for KRW 15.3 billion on May 25, 2021.Under the term of transaction, Green Chemical will acquire 1.2 million share in cash. Board Passed the resolution for transaction on May 25, 2021.Expected closing date is May 25, 2021. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment improved over the past week After last week's 20% share price gain to ₩16,100, the stock trades at a trailing P/E ratio of 36.4x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 368% over the past three years. Valuation Update With 7 Day Price Move • Mar 18
Investor sentiment improved over the past week After last week's 16% share price gain to ₩13,400, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 18x in the Chemicals industry in South Korea. Total returns to shareholders of 296% over the past three years. Ankündigung • Feb 25
Green Chemical Co., Ltd., Annual General Meeting, Mar 24, 2021 Green Chemical Co., Ltd., Annual General Meeting, Mar 24, 2021, at 09:00 Korea Standard Time. Agenda: To consider audit report; to consider business report; to consider appointment report of external auditors; and to consider the report on the operation status of the internal accounting management system. Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment improved over the past week After last week's 20% share price gain to ₩18,950, the stock is trading at a trailing P/E ratio of 40.9x, up from the previous P/E ratio of 34.2x. This compares to an average P/E of 17x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 501%. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improved over the past week After last week's 38% share price gain to ₩13,800, the stock is trading at a trailing P/E ratio of 29.8x, up from the previous P/E ratio of 21.5x. This compares to an average P/E of 16x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 346%. Is New 90 Day High Low • Jan 04
New 90-day high: ₩10,950 The company is up 175% from its price of ₩3,975 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. Upcoming Dividend • Dec 22
Upcoming Dividend of ₩120 Per Share Will be paid on the 10th of April to those who are registered shareholders by the 29th of December. The company last paid an ordinary dividend in March 2011. The average dividend yield among industry peers is 0.9%. Is New 90 Day High Low • Dec 11
New 90-day high: ₩8,580 The company is up 110% from its price of ₩4,090 on 11 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment improved over the past week After last week's 34% share price gain to ₩8,580, the stock is trading at a trailing P/E ratio of 18.5x, up from the previous P/E ratio of 13.8x. This compares to an average P/E of 15x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 163%. Reported Earnings • Nov 22
Third quarter 2020 earnings released: EPS ₩117 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2020 results: Revenue: ₩57.8b (down 7.6% from 3Q 2019). Net income: ₩2.72b (up 18% from 3Q 2019). Profit margin: 4.7% (up from 3.7% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Nov 09
New 90-day high: ₩4,470 The company is up 24% from its price of ₩3,605 on 11 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Valuation Update With 7 Day Price Move • Nov 09
Market bids up stock over the past week After last week's 16% share price gain to ₩4,470, the stock is trading at a trailing P/E ratio of 10x, up from the previous P/E ratio of 8.6x. This compares to an average P/E of 13x in the Chemicals industry in South Korea. Total returns to shareholders over the past three years are 29%. Is New 90 Day High Low • Oct 08
New 90-day high: ₩4,150 The company is up 21% from its price of ₩3,425 on 10 July 2020. The South Korean market is up 11% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 29% over the same period.